sharetrader
  1. #16811
    Legend Balance's Avatar
    Join Date
    Feb 2003
    Posts
    21,620

    Default

    Quote Originally Posted by blackcap View Post
    Pacific Edge (PEB). We expect meaningful sales from
    Cxbladderdetect in calendar 2015 and positive cash flow for the company in
    calendar 2016.

    That aged well.
    Should have been written as 'meaningless sales"?

  2. #16812
    Member
    Join Date
    Mar 2014
    Posts
    415

    Default

    MDX health have had a similar reimbursement experience with their prostate product and have been reimbursed for previous years tests. I look forward to a similar situation possibly happening with PEB. But time will tell. Much easier to sell milk or software unfortunately. Hopefully PEB turn into a CUV situation, surprised nobody above seems to be on that winner.

    Bio tech is expensive, PEB currently have a new clinical/user trial for their monitor product that includes

    Urologists in Urology Centers of Alabama
    Urology Center of Grove Hill, One Lake Street
    Florida Urology Associates
    Idaho Urologic Institute
    Delaware Valley Urology, LLC
    Premier Medical Group of the Hudson Valley
    Weill Cornell Medical College, Department of Urology
    Penn State Hershey Medical Center and College of Medicine
    UT Southwestern Medical Center


    Suppose i could invest in FBU. Didnt they just loose 400 million in a year.

    or even better Summerset who just had 200+ million slugged off their Mcap in the space of a week.

    Good luck to all,

  3. #16813
    Legend Balance's Avatar
    Join Date
    Feb 2003
    Posts
    21,620

    Default

    Quote Originally Posted by Carpenterjoe View Post
    MDX health have had a similar reimbursement experience with their prostate product and have been reimbursed for previous years tests. I look forward to a similar situation possibly happening with PEB. But time will tell. Much easier to sell milk or software unfortunately. Hopefully PEB turn into a CUV situation, surprised nobody above seems to be on that winner.

    Bio tech is expensive, PEB currently have a new clinical/user trial for their monitor product that includes

    Urologists in Urology Centers of Alabama
    Urology Center of Grove Hill, One Lake Street
    Florida Urology Associates
    Idaho Urologic Institute
    Delaware Valley Urology, LLC
    Premier Medical Group of the Hudson Valley
    Weill Cornell Medical College, Department of Urology
    Penn State Hershey Medical Center and College of Medicine
    UT Southwestern Medical Center


    Suppose i could invest in FBU. Didnt they just loose 400 million in a year.

    or even better Summerset who just had 200+ million slugged off their Mcap in the space of a week.

    Good luck to all,
    Or you could have invested in ATM, Serko or Synlait.

    Hard to soar like an eagle if one is stuck on the ground with a bunch of turkeys.

    Or is it a case of being dazzled by PEB's brilliant BS that it's hard to distinguish bull dust with brilliance?
    Last edited by Balance; 08-04-2019 at 09:39 PM.

  4. #16814
    Member
    Join Date
    Nov 2013
    Posts
    123

    Default

    It's been at least three months since PEB last diluted our holdings with another massive discounted insto offer hasn't it? Where's my regularly scheduled devaluation?

  5. #16815
    Legend Balance's Avatar
    Join Date
    Feb 2003
    Posts
    21,620

    Default

    Quote Originally Posted by kyanar View Post
    It's been at least three months since PEB last diluted our holdings with another massive discounted insto offer hasn't it? Where's my regularly scheduled devaluation?
    Be thankful that the sucker institutions are there to prop up this sorry excuse of a biomed company!

    Last placement and capital raising was done at 34c - that's 20% down the drain for them in 2.5 months!

    You can actually buy in cheaper than the sucker instos! Not that it's that hard - the instos are so punch drunk with PEB-induced losses that they would be willing to roll with the next placement (due in September 2020 at this stage).

    Reporting next month - there's a few of us who always look forward to what excuses and stories DD & his board are going to come up with to explain away yet another disappointing delay to the promised $100m revenues!

    This time, it probably will be because of the Mexican border controversy - cannot get health workers, see?

  6. #16816
    Legend Balance's Avatar
    Join Date
    Feb 2003
    Posts
    21,620

    Default

    https://www.healio.com/hematology-on...ncer-detection

    And of course PEB would like you to believe that they have the best in the industry!

    Never mind the fact that it is clear that the top universities and med clinics obviously do not think so!

    Tick ... tick ....

    http://nzx-prod-s7fsd7f98s.s3-websit...925/277893.pdf

    Investor Update must be due and really, there are only 2 questions or update investors and shareholders need :

    1. What happened to Kaiser?

    2. What happened to the CMS reimbursement rate, 6 months from when PEB made the exciting announcement from the ever exuberantly capital raising excited DD?

    "..... The rate, set by the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests, will be open for public comment until 22 October 2018 and will be published in the Clinical Laboratory Fee Schedule in November 2018 and effective from 1 January 2019."

    Oops - it's April 2019!

  7. #16817
    Senior Member
    Join Date
    Apr 2013
    Location
    Pourquoi?
    Posts
    873

    Default

    Quote Originally Posted by Balance View Post
    https://www.healio.com/hematology-on...ncer-detection

    And of course PEB would like you to believe that they have the best in the industry!

    Never mind the fact that it is clear that the top universities and med clinics obviously do not think so!

    Tick ... tick ....

    http://nzx-prod-s7fsd7f98s.s3-websit...925/277893.pdf

    Investor Update must be due and really, there are only 2 questions or update investors and shareholders need :

    1. What happened to Kaiser?

    2. What happened to the CMS reimbursement rate, 6 months from when PEB made the exciting announcement from the ever exuberantly capital raising excited DD?

    "..... The rate, set by the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests, will be open for public comment until 22 October 2018 and will be published in the Clinical Laboratory Fee Schedule in November 2018 and effective from 1 January 2019."

    Oops - it's April 2019!
    The call has gone out for new Directors.

    Would love some info on the board decisions:

    1. Who signed off on the receivables v actual revenue farce and retreat.
    2. Were going to be $100M by 2018 (expired) with no grounding in reality.
    3. Raising $150M for international expansion based on flimsy market research.
    4. DD expenses out of reality with market traction
    5. Poor performing sales team
    6. Potential dividends (lol) estimate. I am guessing 2075 or after?

    Thanks
    Last edited by Schrodinger; 17-04-2019 at 10:54 AM.

  8. #16818
    Guru
    Join Date
    Jul 2002
    Location
    New Zealand.
    Posts
    4,454

    Default

    Quote Originally Posted by Schrodinger View Post
    The call has gone out for new Directors.

    Would love some info on the board decisions:

    1. Who signed off on the receivables v actual revenue farce and retreat.
    2. Were going to be $100M by 2018 (expired) with no grounding in reality.
    3. Raising $150M for international expansion based on flimsy market research.
    4. DD expenses out of reality with market traction
    5. Poor performing sales team
    6. Potential dividends (lol) estimate. I am guessing 2075 or after?

    Thanks
    Smoke and mirror company always has been imho, but too scared to sell my shares

  9. #16819
    Divorced from logic Hectorplains's Avatar
    Join Date
    May 2015
    Location
    Christchurch
    Posts
    684

    Default

    Quote Originally Posted by Schrodinger View Post
    The call has gone out for new Directors.

    Would love some info on the board decisions:

    1. Who signed off on the receivables v actual revenue farce and retreat.
    2. Were going to be $100M by 2018 (expired) with no grounding in reality.
    3. Raising $150M for international expansion based on flimsy market research.
    4. DD expenses out of reality with market traction
    5. Poor performing sales team
    6. Potential dividends (lol) estimate. I am guessing 2075 or after?

    Thanks
    Pretty much pick any previous announcement... and the questions flow. Here's Feb 1 2018

    1. Where are they are with Raffles and expansion into S.E.Asia?
    2. How are the "
    User Programmes" (studies) progressing in Singapore; especially "transitioning" these to commercial customers (i.e. tests that are actually paid for)?
    3. How much is the Singapore 'base' costing PEB? What other sales 'achievements' have they to report more than a year later?

  10. #16820
    Legend Balance's Avatar
    Join Date
    Feb 2003
    Posts
    21,620

    Default

    Quote Originally Posted by whatsup View Post
    Smoke and mirror company always has been imho, but too scared to sell my shares
    Haha - that's how DD and the PEB free-loading clueless bunch have been successfully keeping the sucker instos onside.

    Any day now, see?

    And BTW, we just need another $10m to see us into the next phase of .... 'insert' exciting excitement!

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •